Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Instem

Instem achieves a major milestone, acquires all shares of Xybion from Banerjee Group LLC controlled by Dr. Pradip K. Banerjee
From Instem
Via Business Wire
Instem Announces Acquisition of RockStep Solutions, Inc.
From Instem
Via Business Wire
Instem Announces Provantis® 12: A Powerful Step Forward in Preclinical Study Management
From Instem
Via Business Wire
Driving Pathology Forward: Instem Strengthens Provantis® with Continued Investment and Innovation
From Instem
Via Business Wire
Instem Announces Acquisition of Strong Tower Solutions, Strengthening its Clinical SCE Solutions
From Instem
Via Business Wire
Instem Strengthens Commitment to End-to-End Preclinical Platform Amid Regulatory Evolution
From Instem
Via Business Wire
Instem Introduces Cloud-Hosted Non-GLP Pathology Module for Provantis
From Instem
Via Business Wire
Instem to Showcase Enhanced Provantis Pathology Solution at Upcoming STP Symposium
From Instem
Via Business Wire
Instem Enables Clients to Leverage ICH S1B Weight of Evidence Guideline
From Instem
Via Business Wire
Instem Now Part of ARCHIMED to Further Accelerate Growth and Impact
From Instem
Via Business Wire
Instem Unveils New Additions to Its Leading Computational Toxicology Software Suite
From Instem
Via Business Wire
Instem Awarded EMA Research Grant
From Instem
Via Business Wire
Instem Expands In Silico Toxicology Service To Meet Growing Demand
From Instem
Via Business Wire
Instem Acquires PDS Life Sciences to Help Clients Bring Life Enhancing Products to Market Faster and More Efficiently
From Instem
Via Business Wire
Instem to Release Next Edition of its Leading Computational Toxicology Software Suite
From Instem
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.